| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/22/2001 | WO2001019992A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019836A1 Phosphonic acid derivatives having carboxypeptidase b inhibitory activity |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019826A2 Triazolopyrimidine derivatives |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019776A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001007098A3 A device and method for performing a biological modification of a fluid |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2001000188A3 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000032177A3 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385589A1 Inhibitors of factor xa |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384660A1 Factor ix/factor ixa antibodies and antibody derivatives |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/21/2001 | EP1084270A1 Inhibition of coagulation in blood and blood products |
| 03/21/2001 | EP1084235A1 Human protein c polypeptide |
| 03/21/2001 | EP1084129A1 Cyclic boroproline compounds |
| 03/21/2001 | EP1084123A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect |
| 03/21/2001 | EP1084118A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4- 4-(4pyridyl) benzoyl] piperazine |
| 03/21/2001 | EP1083912A1 Antithrombotic agents |
| 03/21/2001 | CN1288470A Synthetic polysaccharides, their method of prodn. and pharmaceutical compositions contg. same |
| 03/21/2001 | CN1288464A 4-(2-keto-1-benzimidazolynyl) pipeidine compounds as ORL-1 receptor |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1287854A Medicine for detumescence |
| 03/21/2001 | CN1287834A Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/21/2001 | CN1063341C Thrombus-eliminating and brain-invigorating capsule |
| 03/20/2001 | US6204384 Thrombin inhibitor; anticoagulants |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204296 Patient oxygenation using stabilized fluorocarbon emulsions |
| 03/20/2001 | US6204294 IL-8 receptor antagonists |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204268 Cyclic diaza compounds |
| 03/20/2001 | US6204263 Thrombin inhibitors. |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6204036 Stable, freeze dried mixture; parenteral administering |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018031A2 Peptides and pharmaceutical compositions comprising same |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001017990A1 Heterocyclic derivatives as inhibitors of factor xa |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017549A1 Stably storable oxygen transfusion |
| 03/15/2001 | WO2001017530A1 Iron chelators and uses thereof |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2001017349A1 Thrombopoietin mimetics |
| 03/15/2001 | WO2000078779A3 N-pyrazole a2a receptor agonists |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19939044A1 Verwendung von Morphinanderivaten als Arzneimittel Use of morphinan derivatives as medicaments |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |